{"id":360171,"date":"2023-06-19T09:58:11","date_gmt":"2023-06-19T07:58:11","guid":{"rendered":"https:\/\/medizinonline.com\/covid-19-dans-la-pratique-quotidienne-la-possibilite-de-traitement-avec-paxlovid\/"},"modified":"2023-06-19T13:37:42","modified_gmt":"2023-06-19T11:37:42","slug":"covid-19-dans-la-pratique-quotidienne-la-possibilite-de-traitement-avec-paxlovid","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/covid-19-dans-la-pratique-quotidienne-la-possibilite-de-traitement-avec-paxlovid\/","title":{"rendered":"COVID-19 dans la pratique quotidienne : la possibilit\u00e9 de traitement avec PAXLOVID\u00ae."},"content":{"rendered":"\n<p><strong>Les antiviraux peuvent \u00eatre utilis\u00e9s chez les patients COVID-19 pr\u00e9sentant un risque accru de d\u00e9velopper une maladie grave.<sup>1, 2<\/sup> L&#8217;antiviral PAXLOVID\u00ae (Nirmatrelvir  [PF-07321332]  \/ ritonavir) est le seul traitement oral du COVID-19 autoris\u00e9 et recommand\u00e9 en Suisse.<sup>2-4<\/sup> Le traitement de cinq jours peut \u00eatre d\u00e9livr\u00e9 directement par toutes les pharmacies sur ordonnance et par les m\u00e9decins auto-dispensateurs et doit \u00eatre utilis\u00e9 le plus rapidement possible apr\u00e8s un test viral positif pour le SRAS-CoV-2.<sup>1-3<\/sup><\/strong><\/p>\n\n<!--more-->\n\n<p>Dans le webcast, PD Dr. med. Dominique Braun, chef de clinique avec responsabilit\u00e9 \u00e9largie \u00e0 la Clinique des maladies infectieuses et de l&#8217;hygi\u00e8ne hospitali\u00e8re de l&#8217;H\u00f4pital universitaire de Zurich, pr\u00e9sente le traitement antiviral du COVID-19 en Suisse et le Prof. Catia Marzolini, pharmacologue aux Universit\u00e9s de Liverpool et de B\u00e2le et directrice scientifique du  <a href=\"https:\/\/www.covid19-druginteractions.org\/\" target=\"_blank\" rel=\"noopener\">Contr\u00f4leur d&#8217;interaction m\u00e9dicamenteuse COVID-19<\/a><sup>5<\/sup>Ce document indique ce que vous devez savoir sur les interactions m\u00e9dicamenteuses avec PAXLOVID\u00ae.  <\/p>\n\n<figure class=\"wp-block-embed is-type-video is-provider-vimeo wp-block-embed-vimeo wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"2023-03-16_Webinar_COVID_19_im_Praxisalltag__die_Behandlungsm\u00f6glichkeit_mit_PAXLOVID_JBe_2.3\" data-src=\"https:\/\/player.vimeo.com\/video\/822993573?dnt=1&amp;app_id=122963\" width=\"1160\" height=\"653\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" allowfullscreen src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe>\n<\/div><figcaption class=\"wp-element-caption\">webcast dr. braun &amp; prof. marzolini<\/figcaption><\/figure>\n\n<p><strong>R\u00e9f\u00e9rences<\/strong><\/p>\n\n<p>1. Office f\u00e9d\u00e9ral de la sant\u00e9 publique OFSP, Coordination de l&#8217;approvisionnement en m\u00e9dicaments essentiels Covid-19, <a href=\"https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html\" target=\"_blank\" rel=\"noopener\">https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html,<\/a> dernier acc\u00e8s : 20.02.2023<em>.<\/em><br\/>2. soci\u00e9t\u00e9 suisse d&#8217;infectiologie (SSI). Recommandations sur l&#8217;utilisation pr\u00e9coce des th\u00e9rapies Covid-19 et sur les prophylaxies \u00e9tablies par la Soci\u00e9t\u00e9 Suisse d&#8217;Infectiologie (SSI), 06 f\u00e9vrier 2023 <a href=\"https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html\" target=\"_blank\" rel=\"noopener\">https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html,<\/a> dernier acc\u00e8s : 20.02.2023<em>.<\/em><br\/>3. PAXLOVID\u00ae (nirmatrelvir [PF-07321332] et ritonavir) : information professionnelle actuelle disponible sur <a href=\"https:\/\/www.swissmedicinfo.ch\/ShowText.aspx?textType=FI&amp;lang=DE&amp;authNr=68793\" target=\"_blank\" rel=\"noreferrer noopener\">www.swissmedicinfo.ch.<\/a><br\/>4. liste des m\u00e9dicaments autoris\u00e9s en Suisse <a href=\"https:\/\/www.swissmedic.ch\/swissmedic\/de\/home\/services\/listen_neu.html\" target=\"_blank\" rel=\"noopener\">https:\/\/www.swissmedic.ch\/swissmedic\/de\/home\/services\/listen_neu.html,<\/a> dernier acc\u00e8s : 20.02.2023.<br\/>5. COVID-19 Drug Interactions, <a href=\"https:\/\/www.covid19-druginteractions.org\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.covid19-druginteractions.org\/,<\/a> dernier acc\u00e8s : 26.04.2023<em>.<\/em><\/p>\n\n<p>Les r\u00e9f\u00e9rences sont disponibles sur demande. <\/p>\n\n<p><a href=\"https:\/\/medizinonline.com\/fr\/breves-informations-specialisees\/\" target=\"_blank\" rel=\"noreferrer noopener\">L&#8217;information professionnelle succincte sur PAXLOVID\u00ae.  <\/a><\/p>\n\n<p>Vous trouverez l&#8217;information professionnelle actuelle de PAXLOVID\u00ae sur le site <a href=\"https:\/\/www.swissmedicinfo.ch\/ShowText.aspx?textType=FI&amp;lang=DE&amp;authNr=68793\" target=\"_blank\" rel=\"noreferrer noopener\">www.swissmedicinfo.ch<\/a><\/p>\n\n<p>\u25bc Ce m\u00e9dicament fait l&#8217;objet d&#8217;une surveillance suppl\u00e9mentaire. Pour plus d&#8217;informations, voir l&#8217;information professionnelle\/patiente PAXLOVID\u00ae sur <a href=\"https:\/\/www.swissmedicinfo.ch\/ShowText.aspx?textType=FI&amp;lang=DE&amp;authNr=68793\" target=\"_blank\" rel=\"noreferrer noopener\">www.swissmedicinfo.ch<\/a><\/p>\n\n<p>Responsable du contenu et financ\u00e9 par : Pfizer SA, Sch\u00e4renmoosstrasse 99, 8052 Zurich  <\/p>\n\n<p>PP-PAX-CHE-0240 Avril 2023<\/p>\n\n<p>Contribution en ligne depuis le 19\/09\/2023<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les antiviraux peuvent \u00eatre utilis\u00e9s chez les patients COVID-19 pr\u00e9sentant un risque accru de d\u00e9velopper une maladie grave.1, 2 L&#8217;antiviral PAXLOVID\u00ae (Nirmatrelvir [PF-07321332] \/ ritonavir) est le seul traitement oral&hellip;<\/p>\n","protected":false},"author":14,"featured_media":360177,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Webcast Dr. Braun & Prof. Marzolini","footnotes":""},"category":[11345,11428,11549],"tags":[69126],"powerkit_post_featured":[],"class_list":["post-360171","post","type-post","status-publish","format-standard","has-post-thumbnail","category-contenu-des-partenaires","category-infectiologie","category-rx-fr","tag-webcast-fr","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-11 18:40:57","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":360172,"slug":"la-covid-19-nella-pratica-quotidiana-lopzione-di-trattamento-con-paxlovid","post_title":"La COVID-19 nella pratica quotidiana: l'opzione di trattamento con PAXLOVID\u00ae","href":"https:\/\/medizinonline.com\/it\/la-covid-19-nella-pratica-quotidiana-lopzione-di-trattamento-con-paxlovid\/"},"pt_PT":{"locale":"pt_PT","id":360170,"slug":"covid-19-na-pratica-quotidiana-a-opcao-de-tratamento-com-paxlovid","post_title":"COVID-19 na pr\u00e1tica quotidiana: a op\u00e7\u00e3o de tratamento com PAXLOVID\u00ae","href":"https:\/\/medizinonline.com\/pt-pt\/covid-19-na-pratica-quotidiana-a-opcao-de-tratamento-com-paxlovid\/"},"es_ES":{"locale":"es_ES","id":360169,"slug":"covid-19-en-la-practica-diaria-la-opcion-de-tratamiento-con-paxlovid","post_title":"COVID-19 en la pr\u00e1ctica diaria: la opci\u00f3n de tratamiento con PAXLOVID","href":"https:\/\/medizinonline.com\/es\/covid-19-en-la-practica-diaria-la-opcion-de-tratamiento-con-paxlovid\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/360171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=360171"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/360171\/revisions"}],"predecessor-version":[{"id":360180,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/360171\/revisions\/360180"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/360177"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=360171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=360171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=360171"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=360171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}